{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "c0f4a371-8386-498f-9b30-e43a55447f6a",
   "metadata": {},
   "source": [
    "A. Scope & Coverage\n",
    "\n",
    "Index/Basket Coverage:\n",
    "\n",
    "Does the 95% single-ticker equity delta share include index/basket exposures at all, or are those entirely excluded from PAA right now?\n",
    "\n",
    "If excluded, do we already have a plan/design for how to shock them if triggers fire?\n",
    "\n",
    "Other risk types (vega, gamma):\n",
    "\n",
    "Are equity vega and higher-order risks currently excluded from PAA?\n",
    "\n",
    "If so, how significant are they historically, and do we monitor their contribution separately?\n",
    "\n",
    "WWR & Exotic Equities:\n",
    "\n",
    "Are the specific WWR TRS, capped calls, call spreads, etc., included in the new PAA delta shocks, or are they still excluded?\n",
    "\n",
    "FX–Equity Cross Risk:\n",
    "\n",
    "For non-domestic equities, do we have a way to capture quanto or FX-linked equity risk in PAA if it becomes material?"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "01cf0b7c-902f-4153-a133-46f65ac1dcae",
   "metadata": {},
   "source": [
    "B. Monitoring Framework\n",
    "\n",
    "Threshold Rationale:\n",
    "\n",
    "How were the 85% coverage and $10k materiality thresholds chosen?\n",
    "\n",
    "Are these aligned with internal model governance standards or are they ad hoc?\n",
    "\n",
    "Trigger Linkage:\n",
    "\n",
    "If a threshold breach occurs, is it only escalated within VPC/XVA Desk, or does it go into the formal MRM trigger log (e.g., MOD-28848-v3.00-MET-07186)?\n",
    "\n",
    "Historical Baseline:\n",
    "\n",
    "Have we run these coverage/materiality metrics historically (last 6–12 months) to confirm that breaches are rare?\n",
    "\n",
    "P&L Residual Tolerance:\n",
    "\n",
    "Apart from delta coverage, do we track a residual unexplained P&L threshold that would also trigger review?"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "73027a1b-3073-4141-b2f6-a8e5e07acc5a",
   "metadata": {},
   "source": [
    "1. Scope & Risk Coverage\n",
    "\n",
    "Coverage beyond single-name equities\n",
    "\n",
    "How are equity index, ETF, and basket exposures treated?\n",
    "\n",
    "Could excluding them materially understate equity delta in PAA?\n",
    "\n",
    "Other equity risk measures\n",
    "\n",
    "Are equity vega, gamma, and correlation risks excluded?\n",
    "\n",
    "If so, why is that acceptable for PAA completeness?"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8f55a3cd-7e9f-4699-ad44-01e986cd25da",
   "metadata": {},
   "source": [
    "Breach handling\n",
    "\n",
    "If coverage falls below 85% and risk > $10k, what exactly happens?\n",
    "\n",
    "Does it trigger a formal MRM trigger breach and remediation, or just an internal desk review?\n",
    "\n",
    "Historical backtesting of thresholds\n",
    "\n",
    "Have we checked that these thresholds would have worked historically?\n",
    "\n",
    "Were there past cases where the new filter would have excluded material risk?"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "350aa2d8-211f-40fd-bb19-733ef6ca98b3",
   "metadata": {},
   "source": [
    "1.For counterparties like AKAMT, where the unexplained P&L after including equity delta remains relatively large (e.g., $32k), does this still meet the PAA quality thresholds and acceptance criteria?\n",
    "\n",
    "2.Could you provide backtesting results or historical test cases demonstrating that the equity-delta PAA accurately attributes daily XVA P&L for single-ticker exposures across a range of market conditions?\n",
    "\n",
    "3. The fix only covers single-name exposures—what types of equity exposures remain outside PAA scope (e.g., baskets, indices, ETFs)?\n",
    "4. For the remaining 5% of equity risk not included in the single-name equity delta calculation, is the exposure concentrated in specific counterparties or product types?\n",
    "5. Are higher-order equity risks (gamma, vega) excluded from XVA PAA? If so, is there monitoring in place to detect when these risks become material?\n",
    "6. What was the basis for selecting the $10k materiality threshold—was it derived from historical P&L distributions?\n",
    "7. Was any regression testing done to ensure adding equity-delta PAA did not affect unrelated asset classes or total XVA calculation?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d09852d2-ea4b-4094-80ac-9fdba2b1e129",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
